Federated Hermes’s NeoGenomics NEO Stock Holding History

Federated Hermes’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.51M	Buy	172,040 +2,774	+2%	+$26.8K	﹤0.01%	975
2026 Q1	$1.26M	Buy	169,266 +5,118	+3%	+$53.9K	﹤0.01%	1067
2025 Q4	$1.93M	Buy	164,148 +2,485	+2%	+$26.8K	﹤0.01%	971
2025 Q3	$1.25M	Sell	161,663 -20	-0%	-$140	﹤0.01%	1083
2025 Q2	$1.18M	Buy	161,683 +255	+0.2%	+$2.06K	﹤0.01%	1087
2025 Q1	$1.53M	Buy	161,428 +15,887	+11%	+$198K	﹤0.01%	999
2024 Q4	$2.4M	Buy	145,541 +6,086	+4%	+$94.5K	0.01%	893
2024 Q3	$2.06M	Sell	139,455 -3,132	-2%	-$49K	﹤0.01%	923
2024 Q2	$1.98M	Buy	142,587 +11,599	+9%	+$164K	﹤0.01%	926
2024 Q1	$2.06M	Sell	130,988 -18,453	-12%	-$285K	﹤0.01%	928
2023 Q4	$2.42M	Sell	149,441 -160,647	-52%	-$2.63M	0.01%	901
2023 Q3	$3.81M	Sell	310,088 -72,154	-19%	-$1.07M	0.01%	769
2023 Q2	$6.14M	Sell	382,242 -235,901	-38%	-$3.89M	0.02%	650
2023 Q1	$10.8M	Sell	618,143 -790,479	-56%	-$11.3M	0.03%	526
2022 Q4	$13M	Sell	1,408,622 -664,792	-32%	-$6.2M	0.04%	479
2022 Q3	$17.9M	Sell	2,073,414 -602,622	-23%	-$5.98M	0.05%	408
2022 Q2	$21.8M	Buy	2,676,036 +1,986,369	+288%	+$19M	0.06%	368
2022 Q1	$8.38M	Sell	689,667 -1,056,455	-61%	-$22.2M	0.02%	652
2021 Q4	$59.6M	Hold	1,746,122	–	–	0.11%	239
2021 Q3	$84.2M	Buy	1,746,122 +622,222	+55%	+$28.8M	0.16%	180
2021 Q2	$50.8M	Sell	1,123,900 -16	-0%	-$709	0.09%	281
2021 Q1	$54.2M	Buy	1,123,916 +98,825	+10%	+$5.15M	0.11%	252
2020 Q4	$55.2M	Sell	1,025,091 -742	-0.1%	-$33.5K	0.11%	231
2020 Q3	$37.8M	Sell	1,025,833 -344	-0%	-$12.8K	0.09%	261
2020 Q2	$31.8M	Sell	1,026,177 -126,837	-11%	-$3.51M	0.08%	290
2020 Q1	$31.8M	Buy	1,153,014 +325,881	+39%	+$9.76M	0.09%	235
2019 Q4	$24.2M	Sell	827,133 -178,420	-18%	-$4.25M	0.05%	365
2019 Q3	$19.2M	Sell	1,005,553 -612,273	-38%	-$14.4M	0.05%	377
2019 Q2	$35.5M	Buy	1,617,826 +922,362	+133%	+$20.2M	0.09%	246
2019 Q1	$14.2M	Sell	695,464 -61,297	-8%	-$1.07M	0.04%	434
2018 Q4	$9.54M	Sell	756,761 -85,122	-10%	-$1.27M	0.03%	510
2018 Q3	$12.9M	Buy	841,883 +222,983	+36%	+$3.08M	0.03%	483
2018 Q2	$8.11M	Buy	618,900 +71,600	+13%	+$788K	0.02%	528
2018 Q1	$4.47M	Hold	547,300	–	–	0.01%	655
2017 Q4	$4.85M	Hold	547,300	–	–	0.01%	624
2017 Q3	$6.09M	Hold	547,300	–	–	0.02%	511
2017 Q2	$4.9M	Hold	547,300	–	–	0.01%	578
2017 Q1	$4.32M	Hold	547,300	–	–	0.01%	634
2016 Q4	$4.69M	Hold	547,300	–	–	0.01%	581
2016 Q3	$4.5M	Hold	547,300	–	–	0.01%	595
2016 Q2	$4.4M	Hold	547,300	–	–	0.01%	587
2016 Q1	$3.69M	Buy	547,300 +147,300	+37%	+$969K	0.01%	633
2015 Q4	$3.15M	Buy	+400,000	New	+$2.93M	0.01%	704
2014 Q4	–	Sell	-1,605	Closed	-$8K	–	2014
2014 Q3	$8K	Buy	+1,605	New	+$8.24K	﹤0.01%	1768

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Federated Hermes's NEO Position: Q2 2026 in Review

Federated Hermes increased its NeoGenomics (NEO) stake by 1.6% in Q2 2026, buying an estimated $26.8K and bringing the position to 172,040 shares worth $2.51M. The position accounts for ﹤0.01% of the portfolio, ranked #975.

Federated Hermes first reported a position in NEO in Q3 2014 and has held it in 44 quarters since. The position peaked at $84.2M in Q3 2021. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

Federated Hermes held 172,040 shares of NeoGenomics worth $2.51M as of Q2 2026.
Federated Hermes bought 2,774 NeoGenomics shares in Q2 2026, an estimated $26.8K.
NeoGenomics made up ﹤0.01% of Federated Hermes's portfolio in Q2 2026, its #975 holding.
Federated Hermes first reported a position in NeoGenomics in Q3 2014 and has held it in 44 quarters since.
Federated Hermes's NeoGenomics position peaked at $84.2M in Q3 2021.
266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.